QUICKLINKS AND VIEW OPITONS
Acomplia (rimonabant) : 1% of patients dropped out of studies due to anxiety
Friday, November 16, 2007 10:15 am Email this article
One percent of patients given Acomplia (rimonabant) dropped out of studies due to anxiety compared to 0.3 percent given a placebo according to an analysis by Arnie Astrup and others from the University of Copenhagen in Frederiksberg, Denmark. This means that dropouts due to depression are 3 times as likely with Acomplia (rimonabant) than with placebo. REFERENCE
Christensen R, Kristensen PK, Bartels EM, Bliddal H, Astrup A. Efficacy and safety of the weight-loss drug rimonabant: A meta-analysis of randomised trials. Lancet. 2007 Nov 17, 370(9600):1671-72.
AUTHOR’S CONTACT INFORMATION
Prof Arne Astrup
The Department of Human
Nutrition, Faculty of Life Sciences
University of Copenhagen
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.